Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | RARA | P10276 | 1/20 | 0.54 |
| ▸ | RARB | P10826 | 1/20 | 0.54 |
| ▸ | RARG | P13631 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | GRM5 | P41594 | 11/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ACACB | O00763 | 1/20 | 0.40 |
| ▸ | TLR4 | O00206 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8960507 | 0.86 | RARB (0.55) | CYP3A4RARARARBRARGKMT2A | |
| SCHEMBL9425671 | 0.85 | GRM5 (0.51) | CYP3A4RARBRARGKMT2AGRM5 | |
| SCHEMBL8983698 | 0.83 | GRM5 (0.52) | CYP3A4RARBRARGGRM5 | |
| SCHEMBL5413867 | 0.76 | CYP3A4 (0.48) | CYP3A4RARARARBRARGKMT2A | |
| SCHEMBL6411960 | 0.75 | KMT2A (0.52) | CYP3A4RARARARBRARGKMT2A | |
| SCHEMBL8960046 | 0.74 | CYP3A4 (0.48) | CYP3A4RARARARBRARGKMT2A | |
| SCHEMBL9270697 | 0.74 | CYP3A4 (0.77) | CYP3A4RARARARBRARGKMT2A | |
| SCHEMBL8960230 | 0.74 | CYP3A4 (0.52) | CYP3A4RARARARBRARGKMT2A | |
| SCHEMBL1787779 | 0.73 | ACHE (0.57) | KMT2A | |
| SCHEMBL2928318 | 0.73 | CYP3A4 (0.50) | CYP3A4RARARARBRARGKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7173136-A | — | — | None | — | — | JP | disclosed |
| US-5516904-A | SKIN AND IMMUNE DISORDERS; ANTIARTHRITIC AGENTS; WOUND HEALING AGENTS | ALLERGAN, INC. (US) | 1996-05-14 | — | — | US | disclosed |
| EP-0436398-B1 | Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity | ALLERGAN INC (US) | 1996-01-31 | — | — | EP | disclosed |
| JP-H07173136-A | DI-SUBSTITUTED ACETYLENE HAVING RETINOID-LIKE ACTIVITY | ALLERGAN INC | 1995-07-11 | — | — | JP | disclosed |
| US-5414007-A | Skin disorders | ALLERGAN, INC. (US) | 1995-05-09 | — | — | US | disclosed |
| US-5264456-A | Skin disorders, anticarcinogenic agents, antiarthritic agents, immunology or wound healing agents | ALLERGAN, INC. (US) | 1993-11-23 | — | — | US | disclosed |
| US-5175185-A | Antiacne agents | ALLERGAN, INC. (US) | 1992-12-29 | — | — | US | disclosed |
| EP-0436398-A1 | Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity | ALLERGAN, INC. (US) | 1991-07-10 | — | — | EP | disclosed |
| US-5013744-A | Skin disorders | ALLERGAN, INC. (US) | 1991-05-07 | — | — | US | disclosed |